Maria Cherska: Why Female Vascular Biology Matters for Precision Cardiometabolic Medicine
Maria Cherska, The Head of Cardiology Department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», shared a post on LinkedIn about a recent article by Tania Guillemette et al., published in Lipids in Health and Desease, adding:
“We’ve spent decades asking why women develop cardiovascular disease later than men.
Perhaps the better question is:
Why have we spent so little time studying what protects women in the first place?
For years, biomedical research has treated male physiology as the default. Yet lipid metabolism, inflammation, insulin resistance, and even LDL receptor regulation are profoundly influenced by sex hormones, particularly estrogen.
Understanding these mechanisms isn’t just about women’s health.
It’s about improving precision cardiometabolic medicine for everyone.
The future of prevention won’t rely on ‘one-size-fits-all’ risk models—it will account for biology, sex, hormonal status, and metabolic phenotype.
An excellent review that reminds us that sex is not merely a demographic variable—it’s a biological determinant of cardiometabolic disease.”
Title: Exploring sex bias in cardiometabolic diseases
Authors: Tania Guillemette, David Rhainds, Océane Robert, Catherine Mounier

Find more posts featuring Maria Cherska on Hemostasis Today.
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines
-
Nov 15, 2026, 20:50Asmaa Beltagy: Efficacy and Safety of Eltrombopag in SLE-Associated Immune Thrombocytopenia
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?